Search

Theranostic treatment for prostate cancer involves targeting prostate specific membrane antigen (PSMA) on prostate cancer cells – first with a radioactive molecule to reveal the cancer’s spread via a PET (Positron Emission... Read more

Sponsor  Peter MacCallum Cancer Centre  Funding  Victorian Cancer Agency  Principal investigator  Dr Jacqui Frowen, Clinical Lead of Speech Pathology  Contact  Dr... Read more

The data from the consultation process was presented at a planning day to a group of senior staff from each site who were interested in designing and facilitating the program. This group also reviewed the format and content of... Read more

Our Familial Cancer Research Centre combines clinical and laboratory-based research to:  Identify new hereditary cancer predisposition genes  Improve the identification of people with hereditary cancer... Read more

An initiative of the Inherited Cancer Connect Partnership (ICCon), the eviQ Audit study aims to evaluate the impact of the eviQ Cancer Treatments Online guidelines on both clinical practice and patient uptake of risk management... Read more

A collaborative approach is essential to improve targeted cancer prevention, screening, treatment, and research in this group of people and their families. The purpose of the the Inherited Cancer Connect partnership (ICCon) is... Read more